Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ardhanu Kusumanto"'
Autor:
Kiky Martha Ariesaka, Ardhanu Kusumanto, Muhammad Ary Zucha, Nungki Anggorowati, Agil Wahyu Wicaksono, Moch Yunus, Erianto Fanani, Moh Mirza Nuryady
Publikováno v:
Indonesian Journal of Medical Laboratory Science and Technology, Vol 6, Iss 2 (2024)
Activation of Gonadotropin-Releasing Hormone type II Receptors (GnRHR-II) exhibits antiproliferative activity. GnRHR-II is not only expressed exclusively in the pituitary, but also in a variety of tumors. To date, the clinical relevance of GnRHR-II i
Externí odkaz:
https://doaj.org/article/c2499f3fe1b44b9ead23089efc3b46c1
Publikováno v:
Indonesian Journal of Obstetrics and Gynecology, Pp 148-152 (2023)
Objective: To determine the effectiveness of intravenous injection of granisetron compared to ondansetron in preventing nausea and vomiting, we used the MASCC Antiemesis Tool (MAT) in ovarian cancer patients undergoing paclitaxel-carboplatin chemothe
Externí odkaz:
https://doaj.org/article/d86b31b71f884a91be2fea90ef71608d
Autor:
Muhammad Lutfi, Supak Silawani, Agung Dewanto, Shofwal Widad, Irwan Taufiqurrachman, Ardhanu Kusumanto, Nuring Pangastuti
Publikováno v:
International Journal of Infertility & Fetal Medicine. 13:37-41
Autor:
Khabib Mualim, Luthfan Lazuardi, Susanna Hilda Hutajulu, Dahlan Napitupulu, Ardhanu Kusumanto, Herindita Puspitaningtyas
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Background The Indonesian government has applied the cancer "see and treat" method which involves a visual inspection using acetic acid (VIA), followed by a cryotherapy procedure, to reduce the incidence of cervical cancer. However, compliance with t
Autor:
Ardhanu Kusumanto
Publikováno v:
Bali Medical Journal. 9:404-407
Background: The management of advanced epithelial ovarian cancer (EOC) has evolved to become a combination of initial cytoreductive surgery (CRS) followed by chemotherapy. Chemotherapy has been regarded as standard therapy for the majority of women w
Autor:
Herman Susanto, Aditiyono Aditiyono Aditiyono, Ali Budi Harsono, Ardhanu Kusumanto, Supriadi Gandamihardja, Gatot Nyarumenteng Adhipurnawan Winarno
Publikováno v:
Indonesian Journal of Obstetrics & Gynecology Science. 1:40-51
Tujuan : Membandingkan penanda tumor osteopontin (OPN), cancer antigen 125 (CA125), kombinasi sebagai prediktor keganasan pada penderita tumor ovarium. Metode : Penelitian cross sectional ini dilakukan pada pasien dengan keganasan pada kista ovarium
Publikováno v:
Jurnal Kesehatan Reproduksi; Vol 6, No 3 (2019)
JURNAL KESEHATAN REPRODUKSI; Vol 6, No 3 (2019)
JURNAL KESEHATAN REPRODUKSI; Vol 6, No 3 (2019)
Latar Belakang: Kanker serviks merupakan kanker paling banyak ketiga yang ditemukan pada seorang wanita. Secara keseluruhan lebih dari 85% terjadi pada negara-negara berkembang. Insidensi rata-rata paling tinggi di wilayah Sub Sahara Afrika, Amerika
Publikováno v:
Jurnal Kesehatan Reproduksi; Vol 8, No 1 (2021); 23-30
JURNAL KESEHATAN REPRODUKSI; Vol 8, No 1 (2021); 23-30
JURNAL KESEHATAN REPRODUKSI; Vol 8, No 1 (2021); 23-30
Background: According to data from the "Endometrial Cancer Report" by the World Cancer Research Fund and the American Institute for Cancer Research (WCRFI), endometrial cancer is the sixth most common malignancy in the world and is the largest cancer
Publikováno v:
Jurnal Kesehatan Reproduksi; Vol 7, No 1 (2020)
JURNAL KESEHATAN REPRODUKSI; Vol 7, No 1 (2020)
JURNAL KESEHATAN REPRODUKSI; Vol 7, No 1 (2020)
Background: The therapy for stage IIB cervical cancer according to FIGO is concurrent chemoradiation. The neoadjuvant chemotherapy followed by radical hysterectomy is an alternative therapy to improve the survival rate of cancer patients. Cervical ca
Publikováno v:
American Journal of Clinical and Experimental Medicine. 8:104
Ovarian Cancer (OC) is a global health crisis and one of the deadly gynecological cancers among women worldwide. According to 2008-2012 U.S. cancer statistics, 12.7 per 100,000 women were newly diagnosed with ovarian cancer. During that same time per